Costanza Barresi

Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial

Riccardo Masson, Maria Mazurkiewicz-Bełdzińska, Kristy Rose et al. · The Lancet Neurology · 2022 · 104 citations · Full text

Medicine, Neurology, Pharmacotherapy +6

Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study

Claudia A. Chiriboga, Claudio Bruno, Tina Duong et al. · Neurology and Therapy · 2023 · 54 citations · Full text

Medicine, Neurology, Pharmacology +16

Long-Term Visual Outcomes and Morphologic Biomarkers of Vision Loss in Eyes With Diabetic Macular Edema Treated With Anti-VEGF Therapy

Enrico Borrelli, Domenico Grosso, Costanza Barresi et al. · American Journal of Ophthalmology · 2021 · 45 citations · Full text

Medicine, Ophthalmology, Vision Science +17

Capturing the Transition From Intermediate to Neovascular AMD: Longitudinal Inner Retinal Thinning and Factors Associated With Neuronal Loss

Enrico Borrelli, Costanza Barresi, Giorgio Lari et al. · Investigative Ophthalmology & Visual Science · 2023 · 30 citations · Full text

Health Professions, Ophthalmology, Vision Science +17

Assessment of Diabetic Choroidopathy Using Ultra-Widefield Optical Coherence Tomography

Nicolò Nicolini, Beatrice Tombolini, Costanza Barresi et al. · Translational Vision Science & Technology · 2022 · 21 citations · Full text

Health Professions, Ophthalmology, Vision Science +17